Search Results

There are 7465702 results for: content related to: Subject Index

  1. Growth Factor Function in the Development and Maintenance of Midbrain Dopaminergic Neurons: Concepts, Facts and Prospects for TGF-β

    Ciba Foundation Symposium 196 - Growth Factors as Drugs for Neurological and Sensory Disorders

    Klaus Unsicker, Clemens Suter-Crazzalora, Kerstin Krieglstein, Pages: 70–84, 2007

    Published Online : 28 SEP 2007, DOI: 10.1002/9780470514863.ch6

  2. Age-related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies

    Annals of Neurology

    Volume 32, Issue S1, 1992, Pages: S133–S136, Dr. David L Felten, Suzanne Y. Felten, Kathy Steece-Collier, Isao Date and James A. Clemenst

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410320723

  3. Cell Transplantation and Gene Therapy in Parkinson's Disease

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 1, January/February 2011, Pages: 126–158, Dustin R. Wakeman, Hemraj B. Dodiya and Jeffrey H. Kordower

    Version of Record online : 21 JAN 2011, DOI: 10.1002/msj.20233

  4. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice

    European Journal of Neuroscience

    Volume 23, Issue 6, March 2006, Pages: 1671–1675, S. Zechel, J. Jarosik, I. Kiprianova, A. Schober, K. Unsicker and O. von Bohlen und Halbach

    Version of Record online : 16 MAR 2006, DOI: 10.1111/j.1460-9568.2006.04700.x

  5. Anatomical and functional reconstruction of the nigrostriatal system in vitro: Selective innervation of the striatum by dopaminergic neurons

    Journal of Neuroscience Research

    Volume 58, Issue 4, 15 November 1999, Pages: 553–566, H. Becq, O. Bosler, M. Geffard, A. Enjalbert and J.P. Herman

    Version of Record online : 21 OCT 1999, DOI: 10.1002/(SICI)1097-4547(19991115)58:4<553::AID-JNR8>3.0.CO;2-8

  6. Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes

    Glia

    Volume 21, Issue 2, October 1997, Pages: 204–216, Mati Revuelta, José L. Venero, Alberto Machado and Josefina Cano

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-1136(199710)21:2<204::AID-GLIA4>3.0.CO;2-6

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  8. Monitoring Dopamine in the Mesocorticolimbic and Nigrostriatal Systems by Microdialysis: Relevance for Mood Disorders and Parkinson's Disease

    Applications of Microdialysis in Pharmaceutical Science

    Giuseppe Di Giovanni, Massimo Pierucci, Vincenzo Di Matteo, Pages: 93–150, 2011

    Published Online : 25 JUL 2011, DOI: 10.1002/9781118011294.ch4

  9. Long-Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat Brain

    Journal of Neurochemistry

    Volume 64, Issue 4, April 1995, Pages: 1669–1679, Véronique Blanchard, Muriel Chritin, Sheela Vyas, Marc Savasta, Claude Feuerstein, Yves Agid, France Javoy-Agid and Rita Raisman-Vozari

    Version of Record online : 23 NOV 2002, DOI: 10.1046/j.1471-4159.1995.64041669.x

  10. You have free access to this content
    Time Course Changes in the Dopaminergic Nigrostriatal System Following Transection of the Medial Forebrain Bundle: Detection of Oxidatively Modified Proteins in Substantia Nigra

    Journal of Neurochemistry

    Volume 68, Issue 6, June 1997, Pages: 2458–2468, José L. Venero, Mati Revuelta, Josefina Cano and Alberto Machado

    Version of Record online : 18 NOV 2002, DOI: 10.1046/j.1471-4159.1997.68062458.x

  11. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  12. The nigrostriatal dopamine system of aging GFRα-1 heterozygous mice: neurochemistry, morphology and behavior

    European Journal of Neuroscience

    Volume 28, Issue 8, October 2008, Pages: 1557–1568, Vandana Zaman, Heather A. Boger, Ann-Charlotte Granholm, Baerbel Rohrer, Alfred Moore, Mona Buhusi, Greg A. Gerhardt, Barry J. Hoffer and Lawrence D. Middaugh

    Version of Record online : 7 OCT 2008, DOI: 10.1111/j.1460-9568.2008.06456.x

  13. FGF-2 and S100β immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system

    Cell Biology International

    Volume 28, Issue 12, December 2004, Pages: 849–861, G. Chadi and V.C. Gomide

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2004.08.005

  14. Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease

    Synapse

    Volume 62, Issue 12, December 2008, Pages: 920–926, Yasushi Ishida, Keiichi Kawai, Yasuhiro Magata, Kosuke Ebihara, Ryuichiro Takeda, Hiroshi Abe, Mitsuyoshi Yoshimoto, Hiroyuki Hashiguchi, Kei Odagiri, Hisae Matsuo and Toshikazu Nishimori

    Version of Record online : 15 SEP 2008, DOI: 10.1002/syn.20558

  15. Fibroblast growth factor 2 regulates adequate nigrostriatal pathway formation in mice

    Journal of Comparative Neurology

    Volume 520, Issue 17, 1 December 2012, Pages: 3949–3961, Olga Baron, Andreas Ratzka and Claudia Grothe

    Version of Record online : 1 OCT 2012, DOI: 10.1002/cne.23138

  16. You have free access to this content
    Ictal involvement of the nigrostriatal system in subtle seizures of ring chromosome 20 epilepsy

    Epilepsia

    Volume 53, Issue 8, August 2012, Pages: e156–e160, Stefano Meletti, Aglaia Vignoli, Francesca Benuzzi, Pietro Avanzini, Andrea Ruggieri, Matteo Pugnaghi, Paolo Nichelli and Maria Paola Canevini

    Version of Record online : 27 JUN 2012, DOI: 10.1111/j.1528-1167.2012.03568.x

  17. Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset

    Synapse

    Volume 23, Issue 3, July 1996, Pages: 192–200, R.K.B. Pearce, P. Collins, P. Jenner, C. Emmett and C.D. Marsden

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199607)23:3<192::AID-SYN8>3.0.CO;2-3

  18. A tale on animal models of Parkinson's disease

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 993–1002, Erwan Bezard and Serge Przedborski

    Version of Record online : 27 MAY 2011, DOI: 10.1002/mds.23696

  19. Nicotine as a potential neuroprotective agent for Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 947–957, Maryka Quik, Xiomara A. Perez and Tanuja Bordia

    Version of Record online : 12 JUN 2012, DOI: 10.1002/mds.25028

  20. Behavioural Effects of Substance P through Dopaminergic Pathways in the Brain

    Ciba Foundation Symposium 91 - Substance P in the Nervous System

    Ruth Porter, Maeve O'Connor, Pages: 307–337, 2008

    Published Online : 30 MAY 2008, DOI: 10.1002/9780470720738.ch18